| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 139, 1333-1340, Copyright © 1991 by American Society for Investigative Pathology
REGULAR ARTICLES |
P Inki, F Stenback, L Talve and M Jalkanen
Department of Medical Biochemistry, University of Turku, Finland.
Immunoreactivity for syndecan, a cell surface proteoglycan, which binds extracellular matrix molecules and growth factors, was studied in hairless (hr/hr) mice exposed to UV-A and UV-B irradiation. Positive staining was observed at the surface of normal epidermal cells as well as in the dermal abortive hair follicle cysts characteristic to this mouse strain. Early reaction to UV-irradiation showing hyperplastic epidermis with slight cellular atypia showed also positive, although reduced, staining of epidermal cell surfaces. Specimens with severe dysplasia showed weak staining in the granular cell layer, whereas the basal cell layer was negative. In papillomas and keratoacanthomas, immunoreactivity for syndecan was observed in the benign hyperplastic epidermal cells as well as in the proliferating epidermal cells of the horn cysts. Malignant transformation of epithelium, expressed as the formation of early invasive and anaplastic squamous cell carcinomas, was uniformly associated with loss of syndecan staining. These results are consistent with the previous findings of reduced expression of syndecan associated with malignant transformation of cultured epithelial cells, but also suggest an important role for syndecan in the maintenance of normal tissue architecture and differentiation pattern of the skin.
This article has been cited by other articles:
![]() |
Hasengaowa, J. Kodama, T. Kusumoto, Y. Shinyo, N. Seki, and Y. Hiramatsu Prognostic significance of syndecan-1 expression in human endometrial cancer Ann. Onc., July 1, 2005; 16(7): 1109 - 1115. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shinyo, J. Kodama, A. Hongo, M. Yoshinouchi, and Y. Hiramatsu Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer Ann. Onc., October 1, 2003; 14(10): 1505 - 1510. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maatta, P. Jaakkola, and M. Jalkanen Extracellular Matrix-dependent Activation of Syndecan-1 Expression in Keratinocyte Growth Factor-treated Keratinocytes J. Biol. Chem., April 2, 1999; 274(14): 9891 - 9898. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kainulainen, L. Nelimarkka, H. Jarvelainen, M. Laato, M. Jalkanen, and K. Elenius Suppression of Syndecan-1 Expression in Endothelial Cells by Tumor Necrosis Factor-alpha J. Biol. Chem., August 2, 1996; 271(31): 18759 - 18766. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vihinen, A. Määttä, P. Jaakkola, P. Auvinen, and M. Jalkanen Functional Characterization of Mouse Syndecan-1 Promoter J. Biol. Chem., May 24, 1996; 271(21): 12532 - 12541. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Leppa, K Vleminckx, F Van Roy, and M Jalkanen Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent J. Cell Sci., January 6, 1996; 109(6): 1393 - 1403. [Abstract] [PDF] |
||||
![]() |
K Elenius and M Jalkanen Function of the syndecans--a family of cell surface proteoglycans J. Cell Sci., January 11, 1994; 107(11): 2975 - 2982. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |